Insiders · APRE

APRE insider transactions

Aprea Therapeutics Inc. (APRE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for APRE

• 70d
  SEC Form 4 filed by Hamill John P.

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 70d
  SEC Form 4 filed by Peters Richard

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 86d
  President/CEO Gilad Oren was granted 20,175 shares, increasing direct ownership by 5% to 393,895 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 86d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. was granted 10,095 shares, increasing direct ownership by 30% to 43,528 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 128d
  President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 128d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,073 worth of shares (5,700 units at $0.89), increasing direct ownership by 21% to 33,433 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 182d
  Director Duey Marc bought $25,000 worth of shares (21,459 units at $1.17), increasing direct ownership by 9% to 256,155 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 182d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,825 worth of shares (5,000 units at $1.17), increasing direct ownership by 22% to 27,733 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 182d
  SEC Form 4 filed by President/CEO Gilad Oren

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Seizinger Bernd R. was granted 1,045 shares, increasing direct ownership by 2% to 45,775 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Peters Richard was granted 1,045 shares, increasing direct ownership by 50% to 3,119 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Pamukcu Rifat was granted 1,045 shares, increasing direct ownership by 24% to 5,446 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Henneman John B Iii was granted 1,045 shares, increasing direct ownership by 11% to 10,229 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Gruia Gabriela was granted 1,045 shares (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Grissinger Michael was granted 1,045 shares, increasing direct ownership by 57% to 2,889 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Duey Marc was granted 1,045 shares, increasing direct ownership by 0.45% to 234,696 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Bizzari Jean-Pierre was granted 1,045 shares (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 433d
  President/CEO Gilad Oren bought $10,110 worth of shares (5,500 units at $1.84), increasing direct ownership by 2% to 345,620 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 436d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. was granted 3,365 shares, increasing direct ownership by 17% to 22,733 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 436d
  President/CEO Gilad Oren was granted 6,725 shares, increasing direct ownership by 2% to 340,120 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 593d
  Director Duey Marc sold $29,583 worth of shares (6,462 units at $4.58), decreasing direct ownership by 3% to 233,651 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 595d
  President/CEO Gilad Oren bought $1,958 worth of shares (500 units at $3.92), increasing direct ownership by 0.15% to 333,395 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 602d
  Director Duey Marc bought $131,700 worth of shares (30,000 units at $4.39), increasing direct ownership by 14% to 240,113 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 603d
  President/CEO Gilad Oren bought $725 worth of shares (250 units at $2.90), increasing direct ownership by 0.08% to 332,895 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 603d
  Director Duey Marc bought $490 worth of shares (190 units at $2.58), increasing direct ownership by 0.09% to 210,113 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 603d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $123 worth of shares (50 units at $2.46), increasing direct ownership by 0.26% to 19,368 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 604d
  Director Seizinger Bernd R. bought $26,800 worth of shares (10,000 units at $2.68), increasing direct ownership by 29% to 44,730 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 604d
  President/CEO Gilad Oren bought $2,971 worth of shares (1,150 units at $2.58), increasing direct ownership by 0.35% to 332,645 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 604d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $1,174 worth of shares (450 units at $2.61), increasing direct ownership by 2% to 19,318 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Seizinger Bernd R. was granted 1,045 shares, increasing direct ownership by 3% to 34,730 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Pamukcu Rifat was granted 1,045 shares, increasing direct ownership by 31% to 4,401 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Peters Richard was granted 1,045 shares, increasing direct ownership by 102% to 2,074 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Henneman John B Iii was granted 1,045 shares, increasing direct ownership by 13% to 9,184 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Grissinger Michael was granted 1,045 shares, increasing direct ownership by 131% to 1,844 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Duey Marc was granted 1,045 shares, increasing direct ownership by 0.50% to 209,923 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 769d
  Mirza Nadeem Q. was granted 6,730 shares (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 769d
  SEC Form 3 filed by new insider Mirza Nadeem Q.

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 804d
  Hamill John P. was granted 3,365 shares, increasing direct ownership by 22% to 18,868 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 804d
  Gilad Oren was granted 6,725 shares, increasing direct ownership by 2% to 331,495 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 818d
  Hamill John P. bought $7,363 worth of shares (1,010 units at $7.29), increasing direct ownership by 7% to 15,503 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 818d
  Seizinger Bernd R. bought $50,009 worth of shares (6,860 units at $7.29), increasing direct ownership by 26% to 33,685 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 818d
  Henneman John B Iii bought $50,009 worth of shares (6,860 units at $7.29), increasing direct ownership by 536% to 8,139 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 818d
  Gilad Oren bought $14,580 worth of shares (2,000 units at $7.29), increasing direct ownership by 0.62% to 324,770 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Pamukcu Rifat was granted 500 shares and converted options into 321,150 shares, decreasing direct ownership by 57% to 3,356 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Grissinger Michael was granted 500 shares, increasing direct ownership by 167% to 799 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Henneman John B Iii was granted 500 shares, increasing direct ownership by 64% to 1,279 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Peters Richard was granted 500 shares, increasing direct ownership by 95% to 1,029 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Duey Marc converted options into 4,021,300 shares and was granted 500 shares, increasing direct ownership by 32% to 208,878 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Seizinger Bernd R. was granted 500 shares, increasing direct ownership by 2% to 26,825 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4 filed by Bizzari Jean-Pierre

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 3 filed by new insider Bizzari Jean-Pierre

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1098d
  SEC Form 4 filed by Seizinger Bernd R.

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1129d
  SEC Form 4 filed by Gruia Gabriela

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1129d
  SEC Form 3 filed by new insider Gruia Gabriela

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1185d
  SEC Form 4: Gilad Oren converted options into 6,045,100 shares and was granted 4,000 shares, decreasing direct ownership by 2% to 322,770 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1199d
  SEC Form 4: Hamill John P. was granted 1,000 shares, increasing direct ownership by 7% to 14,493 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1227d
  SEC Form 4: Hamill John P. was granted 269,879 shares

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1227d
  SEC Form 3 filed by new insider Hamill John P.

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Seizinger Bernd R. was granted 5,995 shares, increasing direct ownership by 2% to 324,575 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Schade Christian S was granted 32,400 shares, increasing direct ownership by 14% to 259,246 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)